SARS–CoV‐2 infection and COVID‐19 outcomes in rheumatic diseases: a systematic literature review and meta‐analysis
Objective The relative risk of SARS–CoV‐2 infection and COVID‐19 disease severity among
people with rheumatic and musculoskeletal diseases (RMDs) compared to those without …
people with rheumatic and musculoskeletal diseases (RMDs) compared to those without …
The use of non-steroidal anti-inflammatory drugs (NSAIDs) in COVID-19
P Kushner, BH McCarberg, L Grange… - NPJ Primary Care …, 2022 - nature.com
Early in the COVID-19 pandemic, anecdotal reports emerged suggesting non-steroidal anti-
inflammatory drugs (NSAIDs) may increase susceptibility to infection and adversely impact …
inflammatory drugs (NSAIDs) may increase susceptibility to infection and adversely impact …
Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric …
Introduction In light of the SARS-CoV-2 pandemic, protecting vulnerable groups has become
a high priority. Persons at risk of severe disease, for example, those receiving …
a high priority. Persons at risk of severe disease, for example, those receiving …
Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies
L Boekel, M Steenhuis, F Hooijberg… - The Lancet …, 2021 - thelancet.com
Background Data are scarce on immunogenicity of COVID-19 vaccines in patients with
autoimmune diseases, who are often treated with immunosuppressive drugs. We aimed to …
autoimmune diseases, who are often treated with immunosuppressive drugs. We aimed to …
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups
Autoimmune systemic diseases (ASD) may show impaired immunogenicity to COVID-19
vaccines. Our prospective observational multicenter study aimed to evaluate the …
vaccines. Our prospective observational multicenter study aimed to evaluate the …
Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance
MF Ugarte-Gil, GS Alarcón, Z Izadi… - Annals of the …, 2022 - ard.bmj.com
Aim To determine characteristics associated with more severe outcomes in a global registry
of people with systemic lupus erythematosus (SLE) and COVID-19. Methods People with …
of people with systemic lupus erythematosus (SLE) and COVID-19. Methods People with …
Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial
CSR Araujo, AC Medeiros-Ribeiro… - Annals of the …, 2022 - ard.bmj.com
Objective To evaluate the effect on immunogenicity and safety of 2-week methotrexate
(MTX) discontinuation after each dose of the Sinovac-CoronaVac vaccine versus MTX …
(MTX) discontinuation after each dose of the Sinovac-CoronaVac vaccine versus MTX …
Impaired antibody response to the BNT162b2 messenger RNA coronavirus disease 2019 vaccine in patients with systemic lupus erythematosus and rheumatoid …
C Ammitzbøll, LE Bartels… - ACR open …, 2021 - Wiley Online Library
Objective With a vaccine effectiveness of 95% for preventing coronavirus disease 2019
(COVID‐19), Pfizer‐BioNTech BNT162b2 (BNT162b2) was the first vaccine against severe …
(COVID‐19), Pfizer‐BioNTech BNT162b2 (BNT162b2) was the first vaccine against severe …
[HTML][HTML] Коронавирусная болезнь 2019 (COVID-19) и иммуновоспалительные ревматические заболевания. Рекомендации Общероссийской общественной …
ЕЛ Насонов, АМ Лила, ВИ Мазуров… - Научно …, 2021 - cyberleninka.ru
В середине 2021 года инфекция SARS-CoV-2 (Severe Acute Respiratory coronavirus 2),
вызвавшая пандемию коронавирусной болезни 2019 (coronavirus disease, COVID-19) …
вызвавшая пандемию коронавирусной болезни 2019 (coronavirus disease, COVID-19) …
Sex hormones, autoimmunity and gender disparity in COVID-19
HA Raza, P Sen, OA Bhatti, L Gupta - Rheumatology international, 2021 - Springer
Abstract The Coronavirus disease 2019 (COVID-19) pandemic has majorly contributed to
massive and widespread mortality. Epidemiological data strongly indicates a sex-based …
massive and widespread mortality. Epidemiological data strongly indicates a sex-based …